Amdoxovir

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), RFS Pharma, LLC

Conditions

HIV Infections

Phase 1

Adding New Drugs for HIV Infected Patients Failing Current Therapy

CompletedNCT00031044

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 2004-11-30Target: 50Updated: 2021-11-01

Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV

CompletedNCT00432016

RFS Pharma, LLCHIV Infections

Start: 2007-02-28End: 2007-05-31Target: 24Updated: 2007-05-11

Phase 2

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

CompletedNCT00038272

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 2006-04-30Target: 56Updated: 2021-11-01